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Activation of resting B cells to proliferate and differentiate into antibody-
forming cells (AFC)' involves at least two triggering events : (a) binding ofantigen
by the B cell surface Ig (sIg) receptor (1, 2), and (b) T cell help (3) . By using anti-
Ig antibody as an antigen analogue, it has been shown (4, 5, reviewed in 6) that
crosslinking of sIg receptors induces a series of metabolic events leading to B cell
membrane depolarization, an increase in cell surface class II MHC antigen
expression, cell enlargement, entry into G t phase of the cell cycle, and ultimately
B cell proliferation .
T cell help for B cell activation appears to be mediated by both the secretion
of nonspecific soluble products, lymphokines, and direct (cognate) T-B cell
interaction . Although resting B cells are responsive to a number of lymphokines
(7-10), there is evidence in both the murine (11-13) and human (14-16) systems
that optimal activation requires cognate interaction between antigen-specific Th
cells and antigen in conjunction with MHC class II molecules on the B cell
surface . This requirement has been inferred from studies ofB cell proliferation
and AFC generation, events that are several days distal to the presumed Th-B
cell interaction . Indeed, the precise functional consequences for the B cell of
cognate interaction with Th cells remain obscure .
In this study, we have used cloned allospecific human Th cells to investigate
early events in cognate Th-B cell interaction . Our assay system uses an mAb
reactive with a B cell-restricted cell surface activation antigen, BLAST-2 (17) .
The BLAST-2 antigen is a 45,000 dalton polypeptide of unknown function, not
found on peripheral blood or tonsil resting B cells . BLAST-2 is induced on a
small percentage of B cells activated by EBV or B cell mitogens within the first
24 h of culture, before blastogenesis (17-19) . We show that within 16 h of
antigen-specific interaction with Th cells, a significant fraction of resting B cells
express BLAST-2 . This effect results, at least in part, from cognate Th-B cell
interaction as (a) paraformaldehyde-"fixed" Th cells, which can no longer provide
helper factors for B cell differentiation, effectively induce BLAST-2 expression,
and (b) supernatants derived from antigen-activated Th clones trigger minimal
BLAST-2 expression . Finally, B cell activation mediated by crosslinking of the
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`Abbreviations used in this paper:
￿
AFC, antibody-forming cells ; MFI, mean fluorescence intensity ;
SAC, Staphylococcus aureus ; sIg, surface Ig .
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sIg receptor for antigen is a poor stimulus for BLAST-2 expression, suggesting
that the interaction ofantigen with sIg, and Th cells with class 11 MHC molecules,
lead to distinct B cell responses.
Materials and Methods
Preparation of Target B Cell Populations.
￿
Human PBMC or tonsil mononuclear cells,
were isolated on Ficoll-Hypaque density gradients, and T and non-T cells were separated
after rosetting the T cells with neuraminidase-treated sheep red blood cells, as previously
described (20). Non-T cells were suspended at 2 X 106 cells/ml in RPMI 1640 (Gibco
Laboratories, Grand Island, NY) containing 10% FCS (Hazelton-Dutchland, Inc., Denver,
PA), penicillin and streptomycin (50 ,/ml; Gibco Laboratories), 2 mM glutamine (Gibco
Laboratories), henceforth termed culture medium, and were incubated in a horizontally
placed plastic tissue culture flask (No. 3024 ; Falcon Labware, Oxnard, CA) at 37°C, 5%
C02, for 16 h to remove adherent cells.
In some experiments, tonsil nonadherent non-T cells were enriched for high-density
(resting B cell-enriched) B cellson discontinuous Percoll gradients as previously described
(21). High-density populations contained >98% B1 or sIg bearing cells, <1% T3+, and
<1% M02' Cells-
TCell Clones.
￿
The IL-2 dependent human Th clones used in these studies have been
described previously. Allospecific Th clones include clone A-7, which is DR3 reactive
(17); clone A-57, DR2 reactive (17); and clones 33 and 86, DRI reactive (22). Clone E-
11 is specific for TNP-modified cells that express the DR5 antigen (16). All of these Th
clones are T3+, T4+, and T8-, and have been shown to provide MHC-restricted helper
activity for allogeneic B cells as measured by the induction of proliferation and differen-
tiation.
BLAST-2 Induction Assay.
￿
Cultures were established in 1 .25 ml culture medium in 5
ml plastic tubes (No. 2058; Falcon Labware) and contained 1 X 106 B cells and either
medium, 0.25 X 106 allospecific Th clone cells specific for a MHC class II antigen on the
allogeneic B cells (matched), or 0.25 X 106 allospecifc Th clone cells specific for an MHC
class 11 antigen not on the B cells (mismatched). In some experiments, B cells were TNP-
modified, as has been previously described (16), before culture with clone E-11 . Clone E-
11 exhibits a vigorous proliferative response to TNP-modified, but not unmodified, B
cells from donors who are DR5`. Some B cell cultures contained affinity-purified F(ab')2
fragments of goat anti-human IgM coupled to Sepharose beads (donated by Dr. Nicholas
Chiorazzi, The Rockefeller University, New York) at a final concentration of 0 .2%,
soluble F(ab')2 fragments of goat anti-human IgM (Cappel Laboratories, Malvern, PA) at
a concentration of 100 ug/ml, formalin-fixed Staphylococcus aureus organisms (SAC;
Calbiochem-Behring Corp., LaJolla, CA) at a final concentration of 0.05%, IL-2 (Electro-
Nucleonics, Inc ., Silver Spring, MD) at a 10% final concentration (64 half-maximal ['H]
thymidine U/ml), or culture supernatants derived from activated or unactivated Th clones
(see below).
Cultures were incubated at 37°C, 5% C02, for 16 h and then assessed for expression
of BLAST-2 (using EBVCS2 mouse anti-human mAb generously donated by Drs. Bill
Sugden and Stan Metzenberg, McArdle Laboratory for Cancer Research, Madison, WI)
(17), B1 (Coulter Immunology, Hialeah, FL), or sIg, using fluorescein-conjugated F(ab')2
fragments of goat anti-human IgG, IgA, and IgM antibody (Tago Inc., Burlingame, CA).
Immunofluorescence studies were performed as previously described (23) with mouse
anti-human mAbs counterstained with fluorescein-conjugated F(ab')2 fragments of goat
anti-mouse IgG (Tago Inc.). Percentage of positively staining cells was determined on an
Epics V cytofluorograph, gating on the lymphocyte population and counting 10,000 cells
per sample. Results are expressed as percent of the B1 or sIg bearing cells positive for
BLAST-2 after subtraction ofbackground fluorescence (cells incubated with PBS contain-
ing 1 % BSA [PBS-BSA], followed by the fluorescein-goat anti-mouse IgG). Mean fluores-
cence intensity (MFI), on a logarithmic scale, was also recorded.
Paraformaldehyde Fixation.
￿
Some allogeneic B cells were incubated with T cell clone
cells that had been pretreated with paraformaldehyde (Sigma Chemical Co ., St. Louis,1762
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MO) in order to "fix" the T cell membrane and prohibit secretion of T cell factors. 3 X
106 T cell clone cells were incubated with 1 ml 0.05% paraformaldehyde in PBS at room
temperature for 1 min. The reaction was stopped by the addition of RPMI 1640 containing
10% FCS. This procedure has been shown (24, 25) to inhibit cytokine secretion and
protein synthesis by mononuclear cells. The cells were then exhaustively washed before
addition to allogeneic B cells.
Generation of Th Supernatants.
￿
1 .25 X 106 A-57 Th cells were cultured for 6 h in a
final volume of 1 .25 ml of medium with 2.5 X 106 allogeneic non-T cells, which were
irradiated with 2,000 rad from a cesium source. Allogeneic non-T cells were obtained
from donors that were either matched or mismatched for the DR specificity (DR2) of
clone A-57.
PFC Assay.
￿
In some experiments, parallel studies were performed to document that
paraformaldehyde-treated Th clone cells could not induce differentiation of DR-matched
allogeneic B cells to Ig secretion, a function dependent on secretion of factors (22). 0.4 X
106 B cells were cultured with 0 .1 X 106 Th clone cells for 6 d. Ig-secreting cells were
then quantitated using the reverse hemolytic plaque assay, as previously described (22).
Results are expressed as PFC per culture .
Anti-Ig-induced B cell Stimulation.
￿
Parallel studies were performed in some experi-
ments to document the capacity of the anti-Ig preparations to induce B cell proliferation.
0.1 X 106 B cells were incubated, in triplicate, with culture medium, or with medium
containing 0.2% anti-Ig beads or 100 Ag/ml soluble anti-Ig for 3 d at 37 ° C, 5% C02.
Proliferation was assessed by the incorporation of [6H]thymidine (Schwartz-Mann Div.,
Becton-Dickinson Immunodiagnostics, Orangeburg, NY) added during the last 8 h of
culture. [3H]thymidine incorporated by B cellscultured with anti-Ig beads or soluble anti-
Ig was significantly increased, 10-65 times greater than that incorporated by B cells
cultured alone.
Results
BLAST-2 Expression Is Induced on Allogeneic B Cells by MHC Class II Antigen-
specific Cloned Th Cells. To investigate the early consequences of Th-B cell
interaction, we asked if the antigen-specific interactions between Th and B cells
would result in B cell activation antigen expression . To this end, allogeneic B
cells were cocultured with cloned, IL-2-dependent, allospecific Th cells (14, 15,
22) and, after 16 h, assayed by immunofluorescence staining for expression of
the BLAST-2 activation antigen. It should be emphasized that all B cells that
express the DR antigen recognized by an allospecific Th cell are potential targets
for direct Th interaction. This allows an antigen-specific (DR-specific) Th cell-
B cell interaction to be assayed as a "polyclonal" B cell response. BLAST-2 was
chosen as the "marker" antigen as it is a B cell-specific surface membrane
activation antigen that is rapidly (within 24 h) expressed on a small fraction (5-
10%) of resting human B cells triggered by EBV or mitogens (17-19) . Thus,
BLAST-2 expression appears to represent a marker for the initial stages of
resting human B cell activation. The results of six experiments (Table I) show
that allospecific Th cells preferentially induce BLAST-2 expression by allogeneic
B cells that bear the "relevant" DR antigen (i.e., the DR antigen recognized by
the Th cell). The fluorescence histograms of a representative study (Fig. 1) show
the high intensity fluorescence of BLAST-2 staining of B cells that have inter-
acted with Th cells in an antigen-specific manner. In contrast, coculture of
"irrelevant" allospecific Th cells with allogeneic B cells induces very low intensity
BLAST-2 expression on a small percentage of cells. Antigen-specific Th-induced
B cell activation appears to be a particularly potent stimulus for BLAST-2
expression, as 35-84% of the B cells express BLAST-2 after 16 h . ConsistentTABLE I
Early Expression ofBLAST-2 on B Lymphocytes Cultured with HLA Class
II Antigen-matched or -mismatched T Cell Clones
* Peripheral blood nonadherent non-T cells or tonsil nonadherentnon-T cells
(Exp . 6) from six different individuals were cultured for 16 h with culture
medium, with allospecific Th clone cells specific (matched) for an MHC class
Il antigen on the allogeneicB cells, or with Th cells mismatched for theMHC
class II antigens on the B cells, as described in Materials and Methods .
Nonadherent non-T cells from peripheral blood contained a mean of 34%
B1-or s1g-bearing cells . Tonsil non-T cells (Exp . 6) contained 97% B1-or s1g-
bearing cells . Expression of the BLAST-2 antigenand B1 or s1g were assessed
by cytofluorographic analysis . 10,000 cells with the size and light scatter
properties of lymphocytes were analyzed in each sample . Results are expressed
as percent oftheB1- ors1g-bearingcells positive forBLAST-2 after subtraction
of background fluorescence (cells incubated with PBS-BSA followed by fluo-
rescein-goat anti-mouse Ig) .
TheTh clone used in each experiment is noted in parentheses. The specificity
of each clone is described in Materials and Methods .
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FIGURE 1 .
￿
Cytofluorographic analysis of BLAST-2 expression . Allogeneic peripheral blood
B cells were cultured for 16 h with medium (top panels), a DR-matched T cell clone (bottom
left panel), or a DR-mismatchedT cell clone (bottom right panel) . Immunofluorescence studies
were performed as described in Table I, with background fluorescence ofB cellsshown in the
top left paneland BLAST-2 expression shown in the other three panels. Fluorescence intensity
(abscissa) is on a logarithmic scaleand cell number (ordinate) on a linear scale. 10" lymphocytes
persample were counted.
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Exp.
Percent of
Medium
B cells BLAST-2-positive
cultured with:*
MatchedT cell
clone
among B lymphocytes
MismatchedT cell
clone
1 0 66 (A-7)* 6 (A-57)
2 5 84 (A-7) 13 (A-57)
3 2 35 (A-57) 9(33)
4 <1 65(86) 18(E-11)
5 <1 50 (A-7) 10 (A-57)
6 3 35 (A-7) 5 (86), 5 (A-57)1764
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TABLE 11
Early Expression ofBLAST-2 on TNP-modified or Unmodified BLymphocytes Cultured with a
TNP-DR5-specific TCell Clone
* Clone E-I1 cells, specific forTNP-modified DR5 Bcells, were cultured for 16 hwith untreatedor
TNP-modified, nonadherent non-T cells from four different DR5' allogeneic donors, as described
in Materials and Methods. BLAST-2 expression on 111- or sIg-bearing lymphocytes was then
determined on a cytofluorograph, as described in Table 1. In Exp. 3, amismatched allospecific Th
clone (33), and in Exp. 4, a matched allospecific Th clone (A-57), were studied for their capacity
to induce BLAST-2 on TNP-modified and unmodified B cell populations.
with observations in other systems (19), Th cell-induced BLAST-2 expression
requires protein synthesis by the B cells, but not cell division, and is therefore
sensitive to cycloheximide, but resistant to x irradiation (data not shown).
BLAST-2 Expression Is Induced on TNP-modified B Cells by a TNP/altered Self-
reactive Th Clone. The relationship between alloreactive T cells and T cells that
recognize nominal antigen in conjunction with self MHC determinants remains
controversial. We therefore analyzed Th-induced BLAST-2 expression in a
system that involves Th recognition of antigen in conjunction with self MHC.
To this end, we used a hapten/altered self-reactive Th clone termed E-11 (14),
which is specific for TNP in association with the class 11 MHC antigen DR5. As
shown in Table 11, E-11 triggers BLAST-2 expression on TNP-modified, but
not unmodified, DR5 B cells. To rule out the possibility that TNP-modified B
cells are hyperresponsive to activation signals provided by Th cells, we used
matched and mismatched allospecific Th cells as controls. Representative studies
(Table 11) show that Th cell-induced BLAST-2 expression on TNP-modified
and unmodified B cells is comparable. Thus, the resultsobtained with allospecific
and antigen-specific Th cells are analogous.
Kinetics of Th Cell-induced BLAST-2Expression.
￿
Previous studies (19) of EBV-
induced B cell activation showed that BLAST-2 appears early, before B cell
enlargement or DNA synthesis. Therefore, we were interested in determining
the time course of Th-induced BLAST-2 expression . Thus, allogeneic B cells
were cultured alone or in the presence of allospecific Th cells for varying periods
of time, and were assayed for BLAST-2 expression by indirect immunofluores-
cence staining. As depicted in Fig. 2, coculture of B cells with MHC class 11
antigen-specific Th cells results in the appearance of BLAST-2 antigen as early
as 8 hafterthe initiation ofculture, with peak expression by 18 h. Thepercentage
of BLAST-2-bearing B cells subsequently falls off, with a return toward baseline
by day 7 of culture. Allogeneic B cells cultured with medium alone or with
mismatched allospecific Th cells show minimal BLAST-2 expression at all time
Percentof B cells BLAST-2-positive amongB lymphocytes
Exp. Target cells
Medium
cultured with:*
Hapten-altered self
Th clone
Allospecific
Th clone
1 B 1 1 (E-11) ND
BTNP 1 39 (E-I 1) ND
2 BTNP 5 44 (E-11) ND
3 B 6 8 (E-11) 8(33)
BTNP 3 77 (E-11) 16(33)
4 B 1 1 (E-11) 40 (A-57)
BTNP 1 29 (E-11) 34 (A-57)CROW ET AL.
DURATION OF CULTURE (hours)
FIGURE 2.
￿
Kinetics ofBLAST-2expression inducedby allospecific Th cells. Peripheral blood
non-T cells from a DR3+ donor were cultured with medium, a matched (DR3-reactive) Th
clone (A-7), or a mismatched (DR2-reactive) Th clone (A-57), as described in Materials and
Methods. BLAST-2 expression was assessed by indirect immunofluorescence at various time
points afterinitiation of culture. Results areexpressedas percent of B1+ cellsthat are BLAST-
2-positive.
TABLE III
Expression ofBLAST-2 on High-Density Tonsil B Lymphocytes Cultured with
TCell Clone-derived Supernatants
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High-density tonsil B cells, containing >98% sIg+, <1% T3*, and <1%d M02+ cells, were cultured
for 16 h with culture medium, MHC class II antigen-matched or -mismatched Th clone cells,
supernatants derived from antigen-activated or control Th clone cultures, or with 10%d vol/vol
column-purified IL-2. In Exp. 1, supernatants were used at 30% vol/vol final concentration, and
in Exp. 2, at various final concentrations, as noted. BLAST-2 expression was determined as in
Table I. Numbers in parentheses indicate MFI of BLAST-2 expression, after subtraction of
background fluorescence.
points studied. Thus, BLAST-2 expression appears to represent an early conse-
quence of antigen-specific Th cell-induced B cell activation.
Th Cell-induced BLAST-2 Expression Is Accessory Cell Independent.
￿
The con-
tribution of accessory cells to Th-induced BLAST-2 expression was difficult to
evaluate, as the B cell-enriched populations obtained from peripheral blood by
negative selection were often <50% sIg+ or B1 +. To investigate the role of
accessory cells (e.g ., macrophages or dendritic cells) in this response, highly
purified tonsil B cell preparations were studied . As shown in Table 111, Percoll
density gradient-purified small, high-density B cells are readily induced to
express BLAST-2 after coculture with allospecific Th cells. We would emphasize
that these B cell populations are >98% sIg+, <1% T3+, and <1% M0 2+. In
additional studies, treatment of these responder B cell populations with L-leucine
methyl ester, a toxin for monocytes and NK cells (26, 27), did not diminish Th
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Percent of B cellsBLAST-2-positive among B lymphocytes cultured with:*
Exp.
Medium Matched T
cell clone
Mismatched
Tcell clone
ActivatedTh
supernatant
Unactivated
Th superna-
tant
IL-2
1 2(0) 54(22) <1 (5) 14(2) 3(0) 5(2)
2 2(0) 42(24) ND 100% vol/vol 14 (0) 9(3) ND
50% vol/vol 13 (0)
25% vol/vol 12 (0)
3 2(0) 26(16) 7 ND ND 2(0)1766
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TABLE IV
Early Expression ofBLAST-2 on B Lymphocytes Cultured with Paraformaldehyde-treated
HLA Class II Antigen-matched TCell Clones
Percent of B cells BLAST-2-positive among
B lymphocytes cultured with:*
* Peripheral blood nonadherent non-T cells from three different individuals were cultured for 16
h with culture medium, HLA class II antigen-matched Th clone cells, paraformaldehyde-treated
HLA class 11 antigen-matched Th clone cells, or with HLA class II antigen-mismatched Th clone
cells, as described in Materials and Methods. BLAST-2 expression on 131- or sIg-bearing lympho-
cytes was determined as in experiments described in Table I. In Exp. 3, parallel cultures were
established and PFC were assessed after 6d of culture.
cell-induced BLAST-2 expression (data not shown). Together, these studies
suggest that neither allogeneic T cells nor accessory cells are required for Th-
induced BLAST-2 expression .
Th Cell-induced BLAST-2 Expression Is a Consequence of Cognate Interac-
tion. While low-density B cell populations are enriched in cells responsive to a
wide range of lymphokines, including B cell growth and differentiation factors,
a number of recent reports (7-10) have shown that resting B cells can also be
activated by lymphokines. In this regard, we have previously shown (M. K. Crow
and L. Mayer, manuscript submitted for publication) that BLAST-2 expression
can be upregulated, but not induced, by IL-2 . It was important, then, to
investigate whether Th-induced BLAST-2 expression was mediated by cognate
interactions or by Th-derived lymphokines. To study the role of lymphokines in
the induction of BLAST-2 expression by allospecific Th cells, cloned Th cells
were fixed with paraformaldehyde (24) before culture with B cells. As shown in
Table IV, paraformaldehyde fixation of alloreactive Th cells does notalter their
capacity to induce BLAST-2 expression, although it abrogates their capacity to
induce B cell differentiation into PFCs, a function requiring factor production
by the Th cell.
These results suggest that cognate interactions, rather than lymphokines, are
responsible for Th-induced BLAST-2 expression . To approach this point more
directly, supernatants derived from antigen-activated allospecific Th cells were
assayed for BLAST-2-inducing activity on purified tonsil high-density B cells. As
shown in Table III and Fig. 3, these supernatants induce a small percentage of
B cells to express BLAST-2 with low fluorescence intensity. This is most clearly
shown in Fig. 3, but is also documented in Table III by the low MFI of BLAST-
2 expression induced by Th supernatants or IL-2 . In contrast, coculture of Th
cells with the tonsil B cells triggers high fluorescence intensity BLAST-2 expres-
sion on a large proportion of high-density B cells. To rule out the possibility that
the poor BLAST-2 response induced by Th supernatants reflects a limiting
quantity of the relevant lymphokine, varying concentrations of the supernatant
Exp. Medium
Matched Tcell
clone
Paraformalde-
hyde-treated
matched T cell
clone
Mismatched
T cell clone
1 8 34 (A-57) 37 (A-57) 5 (86)
2 2 48 (A-7) 44 (A-7) 8 (A-57)
3 3 66 (A-7) 51 (A-7) 6 (A-57)
PFC/culture 850 10,000 2,000 1,750W m
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FIGURE 3.
￿
Cytofluorographic analysis of BLAST-2 expression on tonsil B cells. High-density
tonsil B cells were cultured for 16 h with medium (top panels), a DR-matched T cell clone
(bottom left), or 100% supernatant derived from a T cell clone activated for 6 h with allogeneic
DR-matched non-T cells (bottom right). Immunofluorescence studies were performed as
described in Table 1. Baseline BLAST-2 expression is shown in the top left panel, sIg expression
is shown in the top right panel, and BLAST-2 expression on the B cells cocultured with Th
cells or with antigen-activated Th supernatant is shown in the bottom left and right panels,
respectively. Histograms obtained using tonsil B cells cultured with 25 and 50% antigen-
activated Th supernatants were similar, in terms of percentage ofBLAST-2-positive cells and
fluorescence intensity, to those seen in the bottom right panel.
were added to a constant number of tonsillar B cells (Table 111, Exp. 2). This
maneuver did not increase either the fluorescence intensity of BLAST-2 or the
proportion of BLAST-2-positive B cells. Taken together with the experiments
shown in Table IV, these data suggest that direct interactions between Th cells
and resting B cells provide the most efficient stimulus for rapid, high-intensity
BLAST-2 expression.
Anti-Ig Is a Poor Stimulus for BLAST-2 Expression.
￿
Crosslinking of the B cell
sIg receptor by anti-Ig antibody provides a potent stimulus for the proliferation
of resting B cells (28-30). We were therefore interested in comparing the effects
of Th cells and anti-Ig antibodies on BLAST-2 expression. Table V shows that
anti-Ig, either soluble or insolubilized on Sepharose beads, is a poor stimulus of
BLAST-2 expression. The small percentage of B cells that express BLAST-2 in
response to anti-Ig show low level fluorescence intensity, similar to that induced
by the Th cell-derived supernatants or IL-2. As positive controls for B cell
activation by anti-Ig, parallel studies were performed and they confirmed that
the anti-Ig induced a proliferative response and the rapid turnover of B cell
membrane phospholipids (Chartash, E., A. Imai, M. Gershengorn, M . Crow, and
S. Friedman; manuscript in preparation). In accord with previous reports (18,
31), B cell activation with SAC is also an inefficient trigger for high-intensity
BLAST-2 expression (Table V, Exps. 7 and 8). These results suggest that
transmembrane signaling of B cells through the interaction of antigen with the
surface Ig receptor on one hand, and the interaction of Th cells with cell surface
MHC class II antigens on the other, may lead to distinctly different cellular
events associated with B cell activation.1768
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TABLE V
BLAST-2 Expression on B Lymphocytes Cultured with Soluble or
SepharoseBead-coupled Anti-Human IgM
* Peripheral blood or tonsil (Exp. 6) nonadherent non-T cellswere cultured for
16 h with culture medium, MHC class II antigen-matched Th clone cells, or
with F(ab')2 fragments of goat anti-human IgM, either coupled to Sepharose
beads (Exps. 1-4, 7 and 8) and used at afinalconcentration of 0.2%, or soluble
at 100 ,ug/ml (Exps. 5 and 6), or with SAC 0.05% . BLAST-2 expression was
determined as describedin Table I.
Discussion
In contrast to the relatively well-characterized cascade of early events that
followsanti-Ig antibody-mediated Bcell activation, no biochemical or functional
marker for the early consequences of direct Th-B cell interaction has been
identified. The experiments described in this report use a panel of cloned
allospecific human Th cells to investigate this issue. Our results show that the
antigen-specific interaction of allospecific Th cells with allogeneic B cells leads
to the rapid (8 h) expression of a B cell-specific activation antigen, BLAST-2,
on a large fraction of resting B cells. Several lines of evidence suggest that Th-
induced BLAST-2 expression is the consequence of cognate Th-B cell interac-
tion. First, the rapid kinetics of Th-induced BLAST-2 expression is similar to
that previously reported (6, 18) for EBV-induced BLAST-2 expression and anti-
Ig antibody-induced hyperexpression of class II MHC antigens, responses that
are mediated by ligand-receptor interactions on the resting B cell surface.
Second, paraformaldehyde treatment of Th clone cells inhibits their induction
of a PFC response by DR-matched allogeneic B cells, but permits BLAST-2
induction at a comparable level to that induced by untreated Th cells. We
presume that at the dose of paraformaldehyde used (0.05%), T cell receptor's
capacity to bind cell surface la remains intact, while the secretion of lymphokines
required for thepolyclonal PFC response isinhibited. In this regard, the identical
fixation protocol used in our studies has been shown (24, 25, 32) to abolish
monokine production and total cellular protein synthesis by macrophages as well
as antigen processing by B cell lymphoblastoid lines. Third, to more directly test
the role of Th-derived factors in BLAST-2 induction, we generated culture
supernatants from alloantigen-activated Th cells. While a small percentage of B
cells cultured with these supernatants express BLAST-2 with low fluorescence
intensity, both the level ofexpression and fraction of BLAST-2-positive B cells
is minimal compared with that induced by direct coculture with allospecific Th
Exp.
Percent of B
Medium
cells BLAST-2-positive
cultured
Matched T cell
clone
among B
with:*
Anti-Ig
lymphocytes
SAC
1 <1 27 (A-7) <1 ND
2 8 94 (A-7) 14 ND
3 <1 77 (E-11) <1 ND
4 6 43 (E-11) 4 ND
5 <1 100 (E-11) 7 ND
6 5 40 (A-57) 10 ND
7 7 24 (A-57) 2 3
8 8 78 (A-7) 15 19CROW ET AL.
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cells. The poor BLAST-2 response induced by supernatants could not be en-
hanced by increasing the quantity of supernatant added to culture. We have
previously shown (Crow, M. K., and L. F. Mayer, manuscript submitted for
publication) that IL-2 cannot induce BLAST-2 but can upregulate BLAST-2
expression on B cells already bearing a small amount of the antigen. Therefore,
the small supernatant-induced BLAST-2 response seen in these experiments may
reflect upregulation of BLAST-2 on a subset of partially activated B cells in the
responder population. Taken together, these data suggest that Th-induced
BLAST-2 expression results from a signal transmitted across the B cell membrane
after the interaction of the T cell receptor with B cell surface MHC class 11
antigens. Although cytokines do not appear essential for this response, our data
do not rule out a role for soluble factors, released by Th cells after antigen-
specific activation, which act locally to upregulate BLAST-2 expression by B cells
that have received a cognate Th stimulus.
If Th-induced BLAST-2 expression results from cognate `fh-B cell interac-
tions, it follows that other cell types should not be required for the response.
Consistent with this interpretation, our studies show that highly purified prepa-
rations of resting B cells (>98% sIg+ or B1+) are efficiently triggered by
allospecific Th cells to express BLAST-2 . While these results suggest that Th-
induced BLAST-2 expression is accessory cell independent, it should be noted
that very small numbers of accessory cells are required to support a number of
in vitro cellular immune responses (26, 33). We cannot, therefore, rule out the
possibility that a small number of these cells are present in our cultures, playing
an obligatory role. Further, our studies use cloned Th cell blasts that are in a
state of continuous activation. It may be that an effective cognate Th-B cell
response induced by resting Th cells will depend more heavily on accessory cell
function.
Cognate Th cell-induced B cell activation appears to be a uniquely potent
stimulus for BLAST-2 expression . Other polyclonal activators of resting B cells,
including anti-Ig antibody, PWM, Staph protein A, and formalinized SAC
organisms have been reported (18, 31) to induce only low fluorescence intensity
BLAST-2 expression on a small fraction of B cells. This result is particularly
striking in view of the fact that anti-Ig antibody activates virtually all resting B
cells, causing them to enlarge, express receptors for B cell growth factor, enter
G, phase of the cell cycle, and, for at least a subset, causes them to undergo cell
division (6, 34). Our studies confirm that anti-Ig, in concentrations that induce
maximal B cell proliferation (and turnover of membrane phospholipids), is an
extremely poor stimulus for BLAST-2 expression. Although the physiologic role,
if any, for BLAST-2 is not known, these observations lead us to speculate that
BLAST-2 expression is associated with the activation of resting B cells to undergo
differentiation, rather than clonal expansion . By using BLAST-2 expression as a
marker of cognate cell-cell interaction, we are currently investigating the possi-
bility that Th cell interaction with B cell surface class II MHC antigens, and anti-
Ig-induced crosslinking of B cell sIg receptors, transduce signals to the B cell
via distinct biochemical "second messenger" systems.
Although maximal BLAST-2 expression is triggered by the interaction of
allospecific Th cells with allogeneic B cells bearing the relevant class 11 MHC
antigen, in many instances, we saw the induction of BLAST-2 on a small1770
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percentage of allogeneic B cells that had been cocultured with irrelevant Th
cells, i.e., Th cells specific for DR antigens that the B cell does not express. This
result was somewhat surprising as the same combination ofirrelevant allospecific
Th cells and allogeneic B cells did not result in any detectable Th cell activation,
assessed either by Th cellproliferation or helper activity for B cell differentiation.
One interpretation ofthis result is that the avidity ofinteraction between the Th
cell receptorforantigen andthe B cell surface DR molecule required forBLAST-
2 induction may be less than that required for Th cell activation . If so, Th-
induced BLAST-2 expression may provide a uniquely sensitive functional assay
for investigating the antigenic structure recognized by the Tcell receptor.
In conclusion, Th cell-induced BLAST-2 expression represents a novel system
for the study of cognate Th-B cell interactions in man. We anticipate that it
should permit the analysis ofthe biochemical and functional changes which these
interactions trigger in the B cell, perhaps giving insight into the mechanism by
which antigen and Th cells synergize in B cell activation.
Summary
We have explored the consequences for the B cell of cognate interaction with
T cells. Early expression of the B cell-restricted cell surface activation antigen,
BLAST-2, has been used as an assay system to measure direct T-B cell collabo-
ration. BLAST-2 is preferentially expressed by allogeneic B cells cultured with
MHC class II antigen-restricted Th clone cells matched to the DR specificity of
the target B cells. B cells cultured with DR-mismatched allospecific Th cells
express minimal BLAST-2. Th cell-induced BLAST-2 expression appears to be
accessory cell independent and occurs as early as 8 h after initiation of culture,
with peak expression at 18 h. Direct T-B cell contact, rather than Th-derived
lymphokines, provides the most efficient stimulus for BLAST-2 expression.
Crosslinking of sIg on B cells is a poor stimulus for BLAST-2 expression . The
BLAST-2 assay permits the evaluation of early events associated with B cell
activation through cognate interactions, and may facilitate subsequent studies of
the mechanism of B cell differentiation.
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